ORGANIC
LETTERS
2008
Vol. 10, No. 8
1593-1595
Catalytic Asymmetric Hydroxylation of
Oxindoles by Molecular Oxygen Using a
Phase-Transfer Catalyst
Daisuke Sano, Kazuhiro Nagata, and Takashi Itoh*
School of Pharmaceutical Sciences, Showa UniVersity, 1-5-8 Hatanodai,
Shinagawa-ku, Tokyo 142-8555, Japan
Received February 5, 2008
ABSTRACT
The highly enantioselective catalytic hydroxylation of 3-substituted oxindoles was achieved by using a phase-transfer catalyst with molecular
oxygen as an oxidant. The product then was converted to an optically active compound 8, which was a synthetic precursor of alkaloid CPC-1.
A number of oxindole alkaloids having a hydroxyl substituent
at their C-3 position possess various bioactivities.1 In the
field of medicinal chemistry, chiral 3-substituted-3-hydroxy-
2-oxindoles have been targets of synthesis, because they are
promising drug candidates.2 Furthermore, they are used as
starting materials and/or intermediates for the synthesis of
natural products.3 The reported methods for the synthesis of
chiral 3-substituted-3-hydroxy-2-oxindoles are an asymmetric
nucleophilic addition to isatins4 and asymmetric hydroxy-
lation of 3-substituted-2-oxindoles.5 In the latter case, a chiral
hydroxylation reagent was used, thus a stoichiometric amount
of the chiral source was required. Recently, the first catalytic
enantioselective hydroxylation of oxindoles with an oxaziri-
dine as an oxidant in the presence of chiral Zn(II) complex
was reported.6 The oxidant resulted in the formation of a
benzisothiazole derivative in the reaction mixture, and it
seems to be a drawback compared to the hydroxylation with
molecular oxygen as an oxidant.7 The use of O2 as an oxidant
is a paramount process, because it is inexpensive and
(1) (a) Tang, Y.-Q.; Sattler, I.; Thiericke, R.; Grabley, S.; Feng, X.-Z.
Eur. J. Org. Chem. 2001, 261. (b) Fre´chard, A.; Fabre, N.; Pe´an, C.;
Montaut, S.; Fauvel, M.-T.; Rollin, P.; Fouraste, I. Tetrahedron Lett. 2001,
42, 9015. (c) Koguchi, Y.; Kohno, J.; Nishino, M.; Takahashi, K.; Okuda,
T.; Ohnuki, T.; Komatsubara, S. J. Antibiot. 2000, 53, 105. (d) Codding, P.
W.; Lee, T. A.; Richardson, J. F. J. Med. Chem. 1984, 27, 649.
(2) (a) Tokunaga, T.; Hume, W. E.; Nagamine, J.; Kawamura, T.; Taiji,
M.; Nagata, R. Bioorg. Med. Chem. Lett. 2005, 15, 1789. (b) Tokunaga,
T.; Hume, W. E.; Umezome, T.; Okazaki, K.; Ueki, Y.; Kumagai, K.;
Hourai, S.; Nagamine, J.; Seki, H.; Taiji, M.; Noguchi, H.; Nagata, R. J.
Med. Chem. 2001, 44, 4641. (c) Hawawasam, P.; Erway, M.; Moon, S. L.;
Knipe, J.; Weiner, H.; Boissard, C. G.; Post-Munson, D. J.; Gao, Q.; Huang,
S;, Gribkoff, V. K.; Meanwell, N. A. J. Med. Chem. 2002, 45, 1487.
(3) (a) Kitajima, M.; Mori, I.; Arai, K.; Kogure, N.; Takayama, H.
Tetrahedron Lett. 2006, 47, 3199. (b) Sua´rez-Castillo, O. R.; Sa´nchez-
Zavala, M.; Mele´ndez-Rodr´ıguez, M.; Castela´n-Duarte, L. E.; Morales-R´ıos,
M. S.; Joseph-Nathan, P. Tetrahedron 2006, 62, 3040. (c) Kawasaki, T.;
Nagaoka, M.; Satoh, T.; Okamoto, A.; Ukon, R.; Ogawa, A. Tetrahedron
2004, 62, 3040.
(5) (a) Hewawasam, P.; Meanwell, N. A.; Gribkoff, V. K.; Dworetzky,
S. I.; Biossard, C. G. Bioorg. Med. Chem. Lett. 1997, 7, 1255. (b)
Hewawasam, P.; Erway, M.; Moon, S. L.; Knipe, J.; Weiner, H.; Boissard,
C. G.; Post-Munson, D. J.; Gao, Q.; Huang, S.; Gribkoff, V. K.; Meanwell,
N. A. J. Med. Chem. 2002, 45, 1487.
(6) Ishimaru, T.; Shibata, N.; Nagi, J.; Nakamura, S.; Toru, T.; Kanemasa,
S. J. Am. Chem. Soc. 2006, 128, 16488.
(7) There are some examples concerning racemic hydroxylation using
molecular oxygen, see: (a) Christoffer, J.; Baro, A.; Werner, T. AdV. Synth.
Catal. 2004, 346, 143. (b) Christoffer, J.; Werner, T.; Frey, W.; Baro, A.
Chem. Eur. J. 2004, 10, 1042. There are three examples concerning the
catalytic enantioselective hydroxylation of tetralone and indanone derivatives
using molecular oxygen, see: (c) Dehmlow, E. V.; Wagner, S.; Mu¨lller,
A. Tetrahedron 1999, 55, 6335. (d) De Vries, E. F. J.; Ploeg, L.; Colao,
M.; Brussee, J.; Van der Gen, A. Tetrahedron: Asymmetry 1995, 6, 1123.
(e) Masui, M.; Ando, A.; Shioiri, T. Tetrahedron Lett. 1988, 29, 2835.
(4) (a) Shintani, R.; Inoue, M.; Hayashi, T. Angew. Chem., Int. Ed. 2006,
45, 3353. (b) Toullec, P. Y.; Jagt, R. B. C.; de Vries, J. G.; Feringa, B. L.;
Minnaard, A. J. Org. Lett. 2006, 8. 2715. (c) Nakamura, T.; Shirokawa, S.;
Hosokawa, S.; Nakazaki, A.; Kobayashi, S. Org. Lett. 2006, 8. 677. (d)
Luppi, G.; Cozzi, P. G.; Monari, M.; Kaptein, B.; Broxterman, Q. B.;
Tomasini, C. J. Org. Chem. 2005, 70, 7418.
10.1021/ol800260r CCC: $40.75
© 2008 American Chemical Society
Published on Web 03/19/2008